MedPath

Guangzhou Cellprotek Pharmaceutical Co., Ltd.

Guangzhou Cellprotek Pharmaceutical Co., Ltd. logo
🇨🇳China
Ownership
Private, Subsidiary
Established
2011-04-26
Employees
11
Market Cap
-
Website
http://www.cellprotek.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects

Phase 1
Conditions
Ischemic Stroke
Interventions
Drug: Vehicle
First Posted Date
2017-12-02
Last Posted Date
2017-12-06
Lead Sponsor
Guangzhou Cellprotek Pharmaceutical Co., Ltd.
Target Recruit Count
32
Registration Number
NCT03358901
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

News

No news found
© Copyright 2025. All Rights Reserved by MedPath